APO Research
Talk to an analyst

APO RESEARCH · REPORT

Venous Leg Ulcers Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Venous Leg Ulcers Treatment Industry Research Report 2026

22 December 2025126 pages

Choose your research edition.

Industry ResearchVenous Leg Ulcers Treatment Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Venous Leg Ulcers Treatment Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Venous Leg Ulcers Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Venous Leg Ulcers Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Venous Leg Ulcers Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Venous Leg Ulcers Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Venous Leg Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Venous Leg Ulcers Treatment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Venous Leg Ulcers Treatment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Venous Leg Ulcers Treatment include Stratatech Corp, RMB-Research GmbH, RegeneRx Biopharmaceuticals Inc, Promore Pharma, NovaLead Pharma Pvt Ltd, MediWound Ltd, Leap Therapeutics Inc, Hypo-Stream Ltd and GangaGen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Venous Leg Ulcers Treatment market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Venous Leg Ulcers Treatment Market by Company

Stratatech Corp

RMB-Research GmbH

RegeneRx Biopharmaceuticals Inc

Promore Pharma

NovaLead Pharma Pvt Ltd

MediWound Ltd

Leap Therapeutics Inc

Hypo-Stream Ltd

GangaGen Inc

FirstString Research Inc

Factor Therapeutics Ltd

Daval International Ltd

CytoTools AG

CardioVascular BioTherapeutics Inc

Venous Leg Ulcers Treatment Segment by Type

HP-802247

Granexin

CVBT-141B

CureXcell

Others

Venous Leg Ulcers Treatment Segment by Application

Hospital

Clinic

Home Use

Venous Leg Ulcers Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venous Leg Ulcers Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Venous Leg Ulcers Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venous Leg Ulcers Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Venous Leg Ulcers Treatment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Venous Leg Ulcers Treatment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Venous Leg Ulcers Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Venous Leg Ulcers Treatment Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Venous Leg Ulcers Treatment Sales (k units) of Manufacturers (2021-2026) Table 7. Global Venous Leg Ulcers Treatment Sales Market Share by Manufacturers (2021-2026) Table 8. Global Venous Leg Ulcers Treatment Revenue of Manufacturers (2021-2026) Table 9. Global Venous Leg Ulcers Treatment Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Venous Leg Ulcers Treatment Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Venous Leg Ulcers Treatment Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Venous Leg Ulcers Treatment, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Venous Leg Ulcers Treatment, Product Type & Application Table 14. Global Venous Leg Ulcers Treatment Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Venous Leg Ulcers Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Stratatech Corp Company Information Table 19. Stratatech Corp Business Overview Table 20. Stratatech Corp Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Stratatech Corp Venous Leg Ulcers Treatment Product Portfolio Table 22. Stratatech Corp Recent Developments Table 23. RMB-Research GmbH Company Information Table 24. RMB-Research GmbH Business Overview Table 25. RMB-Research GmbH Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. RMB-Research GmbH Venous Leg Ulcers Treatment Product Portfolio Table 27. RMB-Research GmbH Recent Developments Table 28. RegeneRx Biopharmaceuticals Inc Company Information Table 29. RegeneRx Biopharmaceuticals Inc Business Overview Table 30. RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Product Portfolio Table 32. RegeneRx Biopharmaceuticals Inc Recent Developments Table 33. Promore Pharma Company Information Table 34. Promore Pharma Business Overview Table 35. Promore Pharma Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Promore Pharma Venous Leg Ulcers Treatment Product Portfolio Table 37. Promore Pharma Recent Developments Table 38. NovaLead Pharma Pvt Ltd Company Information Table 39. NovaLead Pharma Pvt Ltd Business Overview Table 40. NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Product Portfolio Table 42. NovaLead Pharma Pvt Ltd Recent Developments Table 43. MediWound Ltd Company Information Table 44. MediWound Ltd Business Overview Table 45. MediWound Ltd Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. MediWound Ltd Venous Leg Ulcers Treatment Product Portfolio Table 47. MediWound Ltd Recent Developments Table 48. Leap Therapeutics Inc Company Information Table 49. Leap Therapeutics Inc Business Overview Table 50. Leap Therapeutics Inc Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Leap Therapeutics Inc Venous Leg Ulcers Treatment Product Portfolio Table 52. Leap Therapeutics Inc Recent Developments Table 53. Hypo-Stream Ltd Company Information Table 54. Hypo-Stream Ltd Business Overview Table 55. Hypo-Stream Ltd Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Hypo-Stream Ltd Venous Leg Ulcers Treatment Product Portfolio Table 57. Hypo-Stream Ltd Recent Developments Table 58. GangaGen Inc Company Information Table 59. GangaGen Inc Business Overview Table 60. GangaGen Inc Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. GangaGen Inc Venous Leg Ulcers Treatment Product Portfolio Table 62. GangaGen Inc Recent Developments Table 63. FirstString Research Inc Company Information Table 64. FirstString Research Inc Business Overview Table 65. FirstString Research Inc Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. FirstString Research Inc Venous Leg Ulcers Treatment Product Portfolio Table 67. FirstString Research Inc Recent Developments Table 68. Factor Therapeutics Ltd Company Information Table 69. Factor Therapeutics Ltd Business Overview Table 70. Factor Therapeutics Ltd Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Factor Therapeutics Ltd Venous Leg Ulcers Treatment Product Portfolio Table 72. Factor Therapeutics Ltd Recent Developments Table 73. Daval International Ltd Company Information Table 74. Daval International Ltd Business Overview Table 75. Daval International Ltd Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Daval International Ltd Venous Leg Ulcers Treatment Product Portfolio Table 77. Daval International Ltd Recent Developments Table 78. CytoTools AG Company Information Table 79. CytoTools AG Business Overview Table 80. CytoTools AG Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. CytoTools AG Venous Leg Ulcers Treatment Product Portfolio Table 82. CytoTools AG Recent Developments Table 83. CardioVascular BioTherapeutics Inc Company Information Table 84. CardioVascular BioTherapeutics Inc Business Overview Table 85. CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Product Portfolio Table 87. CardioVascular BioTherapeutics Inc Recent Developments Table 88. Global Venous Leg Ulcers Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Venous Leg Ulcers Treatment Sales by Region (2021-2026) & (k units) Table 90. Global Venous Leg Ulcers Treatment Sales Market Share by Region (2021-2026) Table 91. Global Venous Leg Ulcers Treatment Sales by Region (2027-2032) & (k units) Table 92. Global Venous Leg Ulcers Treatment Sales Market Share by Region (2027-2032) Table 93. Global Venous Leg Ulcers Treatment Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Venous Leg Ulcers Treatment Revenue Market Share by Region (2021-2026) Table 95. Global Venous Leg Ulcers Treatment Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Venous Leg Ulcers Treatment Revenue Market Share by Region (2027-2032) Table 97. North America Venous Leg Ulcers Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Venous Leg Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 99. North America Venous Leg Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 100. North America Venous Leg Ulcers Treatment Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Venous Leg Ulcers Treatment Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Venous Leg Ulcers Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Venous Leg Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 104. Europe Venous Leg Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 105. Europe Venous Leg Ulcers Treatment Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Venous Leg Ulcers Treatment Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Venous Leg Ulcers Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Venous Leg Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 109. Asia Pacific Venous Leg Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 110. Asia Pacific Venous Leg Ulcers Treatment Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Venous Leg Ulcers Treatment Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Venous Leg Ulcers Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Venous Leg Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 114. South America Venous Leg Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 115. South America Venous Leg Ulcers Treatment Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Venous Leg Ulcers Treatment Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Venous Leg Ulcers Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Venous Leg Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 119. Middle East and Africa Venous Leg Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 120. Middle East and Africa Venous Leg Ulcers Treatment Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Venous Leg Ulcers Treatment Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Venous Leg Ulcers Treatment Sales by Type (2021-2026) & (k units) Table 123. Global Venous Leg Ulcers Treatment Sales by Type (2027-2032) & (k units) Table 124. Global Venous Leg Ulcers Treatment Sales Market Share by Type (2021-2026) Table 125. Global Venous Leg Ulcers Treatment Sales Market Share by Type (2027-2032) Table 126. Global Venous Leg Ulcers Treatment Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Venous Leg Ulcers Treatment Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Venous Leg Ulcers Treatment Revenue Market Share by Type (2021-2026) Table 129. Global Venous Leg Ulcers Treatment Revenue Market Share by Type (2027-2032) Table 130. Global Venous Leg Ulcers Treatment Price by Type (2021-2026) & (US$/unit) Table 131. Global Venous Leg Ulcers Treatment Price by Type (2027-2032) & (US$/unit) Table 132. Global Venous Leg Ulcers Treatment Sales by Application (2021-2026) & (k units) Table 133. Global Venous Leg Ulcers Treatment Sales by Application (2027-2032) & (k units) Table 134. Global Venous Leg Ulcers Treatment Sales Market Share by Application (2021-2026) Table 135. Global Venous Leg Ulcers Treatment Sales Market Share by Application (2027-2032) Table 136. Global Venous Leg Ulcers Treatment Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Venous Leg Ulcers Treatment Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Venous Leg Ulcers Treatment Revenue Market Share by Application (2021-2026) Table 139. Global Venous Leg Ulcers Treatment Revenue Market Share by Application (2027-2032) Table 140. Global Venous Leg Ulcers Treatment Price by Application (2021-2026) & (US$/unit) Table 141. Global Venous Leg Ulcers Treatment Price by Application (2027-2032) & (US$/unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Venous Leg Ulcers Treatment Distributors List Table 145. Venous Leg Ulcers Treatment Customers List Table 146. Venous Leg Ulcers Treatment Industry Trends Table 147. Venous Leg Ulcers Treatment Industry Drivers Table 148. Venous Leg Ulcers Treatment Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Venous Leg Ulcers Treatment Product Image Figure 5. Global Venous Leg Ulcers Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Venous Leg Ulcers Treatment Market Size (2021-2032) & (US$ Million) Figure 7. Global Venous Leg Ulcers Treatment Sales (2021-2032) & (k units) Figure 8. Global Venous Leg Ulcers Treatment Average Price (US$/unit) & (2021-2032) Figure 9. HP-802247 Product Image Figure 10. Granexin Product Image Figure 11. CVBT-141B Product Image Figure 12. CureXcell Product Image Figure 13. Others Product Image Figure 14. Hospital Product Image Figure 15. Clinic Product Image Figure 16. Home Use Product Image Figure 17. Global Venous Leg Ulcers Treatment Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Venous Leg Ulcers Treatment, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Venous Leg Ulcers Treatment Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Venous Leg Ulcers Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Venous Leg Ulcers Treatment Sales by Region in 2025 Figure 23. Global Venous Leg Ulcers Treatment Revenue by Region in 2025 Figure 24. North America Venous Leg Ulcers Treatment Market Size by Country in 2025 Figure 25. North America Venous Leg Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 26. North America Venous Leg Ulcers Treatment Revenue Market Share by Country (2021-2032) Figure 27. United States Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Venous Leg Ulcers Treatment Market Size by Country in 2025 Figure 31. Europe Venous Leg Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 32. Europe Venous Leg Ulcers Treatment Revenue Market Share by Country (2021-2032) Figure 33. Germany Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Venous Leg Ulcers Treatment Market Size by Country in 2025 Figure 44. Asia Pacific Venous Leg Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Venous Leg Ulcers Treatment Revenue Market Share by Country (2021-2032) Figure 46. China Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Venous Leg Ulcers Treatment Market Size by Country in 2025 Figure 55. South America Venous Leg Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 56. South America Venous Leg Ulcers Treatment Revenue Market Share by Country (2021-2032) Figure 57. Brazil Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Venous Leg Ulcers Treatment Market Size by Country in 2025 Figure 61. Middle East and Africa Venous Leg Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Venous Leg Ulcers Treatment Revenue Market Share by Country (2021-2032) Figure 63. Egypt Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Venous Leg Ulcers Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Venous Leg Ulcers Treatment Sales Market Share by Type (2021-2032) Figure 69. Global Venous Leg Ulcers Treatment Revenue Market Share by Type (2021-2032) Figure 70. Global Venous Leg Ulcers Treatment Price (US$/unit) by Type (2021-2032) Figure 71. Global Venous Leg Ulcers Treatment Sales Market Share by Application (2021-2032) Figure 72. Global Venous Leg Ulcers Treatment Revenue Market Share by Application (2021-2032) Figure 73. Global Venous Leg Ulcers Treatment Price (US$/unit) by Application (2021-2032) Figure 74. Venous Leg Ulcers Treatment Value Chain Figure 75. Venous Leg Ulcers Treatment Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Venous Leg Ulcers Treatment Industry Opportunities and Challenges

Scope & coverage.

Types
  • HP-802247
  • Granexin
  • CVBT-141B
  • CureXcell
  • Others
Applications
  • Hospital
  • Clinic
  • Home Use
Companies covered
  • Stratatech Corp
  • RMB-Research GmbH
  • RegeneRx Biopharmaceuticals Inc
  • Promore Pharma
  • NovaLead Pharma Pvt Ltd
  • MediWound Ltd
  • Leap Therapeutics Inc
  • Hypo-Stream Ltd
  • GangaGen Inc
  • FirstString Research Inc
  • Factor Therapeutics Ltd
  • Daval International Ltd
  • CytoTools AG
  • CardioVascular BioTherapeutics Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Venous Leg Ulcers Treatment Market Size (2021-2032)
  4. 2.2.2 Global Venous Leg Ulcers Treatment Sales (2021-2032)
  5. 2.2.3 Global Venous Leg Ulcers Treatment Market Average Price (2021-2032)
  6. 2.3 Venous Leg Ulcers Treatment by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 HP-802247
  9. 2.3.3 Granexin
  10. 2.3.4 CVBT-141B
  11. 2.3.5 CureXcell
  12. 2.3.6 Others
  13. 2.4 Venous Leg Ulcers Treatment by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Hospital
  16. 2.4.3 Clinic
  17. 2.4.4 Home Use
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Venous Leg Ulcers Treatment Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Venous Leg Ulcers Treatment Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Venous Leg Ulcers Treatment Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Venous Leg Ulcers Treatment Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Venous Leg Ulcers Treatment Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Venous Leg Ulcers Treatment, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Venous Leg Ulcers Treatment, Product Type & Application
  8. 3.8 Global Manufacturers of Venous Leg Ulcers Treatment, Established Date
  9. 3.9 Global Venous Leg Ulcers Treatment Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Stratatech Corp
  2. 4.1.1 Stratatech Corp Company Information
  3. 4.1.2 Stratatech Corp Business Overview
  4. 4.1.3 Stratatech Corp Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Stratatech Corp Venous Leg Ulcers Treatment Product Portfolio
  6. 4.1.5 Stratatech Corp Recent Developments
  7. 4.2 RMB-Research GmbH
  8. 4.2.1 RMB-Research GmbH Company Information
  9. 4.2.2 RMB-Research GmbH Business Overview
  10. 4.2.3 RMB-Research GmbH Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 RMB-Research GmbH Venous Leg Ulcers Treatment Product Portfolio
  12. 4.2.5 RMB-Research GmbH Recent Developments
  13. 4.3 RegeneRx Biopharmaceuticals Inc
  14. 4.3.1 RegeneRx Biopharmaceuticals Inc Company Information
  15. 4.3.2 RegeneRx Biopharmaceuticals Inc Business Overview
  16. 4.3.3 RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Product Portfolio
  18. 4.3.5 RegeneRx Biopharmaceuticals Inc Recent Developments
  19. 4.4 Promore Pharma
  20. 4.4.1 Promore Pharma Company Information
  21. 4.4.2 Promore Pharma Business Overview
  22. 4.4.3 Promore Pharma Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Promore Pharma Venous Leg Ulcers Treatment Product Portfolio
  24. 4.4.5 Promore Pharma Recent Developments
  25. 4.5 NovaLead Pharma Pvt Ltd
  26. 4.5.1 NovaLead Pharma Pvt Ltd Company Information
  27. 4.5.2 NovaLead Pharma Pvt Ltd Business Overview
  28. 4.5.3 NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Product Portfolio
  30. 4.5.5 NovaLead Pharma Pvt Ltd Recent Developments
  31. 4.6 MediWound Ltd
  32. 4.6.1 MediWound Ltd Company Information
  33. 4.6.2 MediWound Ltd Business Overview
  34. 4.6.3 MediWound Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 MediWound Ltd Venous Leg Ulcers Treatment Product Portfolio
  36. 4.6.5 MediWound Ltd Recent Developments
  37. 4.7 Leap Therapeutics Inc
  38. 4.7.1 Leap Therapeutics Inc Company Information
  39. 4.7.2 Leap Therapeutics Inc Business Overview
  40. 4.7.3 Leap Therapeutics Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Leap Therapeutics Inc Venous Leg Ulcers Treatment Product Portfolio
  42. 4.7.5 Leap Therapeutics Inc Recent Developments
  43. 4.8 Hypo-Stream Ltd
  44. 4.8.1 Hypo-Stream Ltd Company Information
  45. 4.8.2 Hypo-Stream Ltd Business Overview
  46. 4.8.3 Hypo-Stream Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Hypo-Stream Ltd Venous Leg Ulcers Treatment Product Portfolio
  48. 4.8.5 Hypo-Stream Ltd Recent Developments
  49. 4.9 GangaGen Inc
  50. 4.9.1 GangaGen Inc Company Information
  51. 4.9.2 GangaGen Inc Business Overview
  52. 4.9.3 GangaGen Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 GangaGen Inc Venous Leg Ulcers Treatment Product Portfolio
  54. 4.9.5 GangaGen Inc Recent Developments
  55. 4.10 FirstString Research Inc
  56. 4.10.1 FirstString Research Inc Company Information
  57. 4.10.2 FirstString Research Inc Business Overview
  58. 4.10.3 FirstString Research Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 FirstString Research Inc Venous Leg Ulcers Treatment Product Portfolio
  60. 4.10.5 FirstString Research Inc Recent Developments
  61. 4.11 Factor Therapeutics Ltd
  62. 4.11.1 Factor Therapeutics Ltd Company Information
  63. 4.11.2 Factor Therapeutics Ltd Business Overview
  64. 4.11.3 Factor Therapeutics Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Factor Therapeutics Ltd Venous Leg Ulcers Treatment Product Portfolio
  66. 4.11.5 Factor Therapeutics Ltd Recent Developments
  67. 4.12 Daval International Ltd
  68. 4.12.1 Daval International Ltd Company Information
  69. 4.12.2 Daval International Ltd Business Overview
  70. 4.12.3 Daval International Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Daval International Ltd Venous Leg Ulcers Treatment Product Portfolio
  72. 4.12.5 Daval International Ltd Recent Developments
  73. 4.13 CytoTools AG
  74. 4.13.1 CytoTools AG Company Information
  75. 4.13.2 CytoTools AG Business Overview
  76. 4.13.3 CytoTools AG Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 CytoTools AG Venous Leg Ulcers Treatment Product Portfolio
  78. 4.13.5 CytoTools AG Recent Developments
  79. 4.14 CardioVascular BioTherapeutics Inc
  80. 4.14.1 CardioVascular BioTherapeutics Inc Company Information
  81. 4.14.2 CardioVascular BioTherapeutics Inc Business Overview
  82. 4.14.3 CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Product Portfolio
  84. 4.14.5 CardioVascular BioTherapeutics Inc Recent Developments
5 Global Venous Leg Ulcers Treatment Market Scenario by Region
  1. 5.1 Global Venous Leg Ulcers Treatment Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Venous Leg Ulcers Treatment Sales by Region: 2021-2032
  3. 5.2.1 Global Venous Leg Ulcers Treatment Sales by Region: 2021-2026
  4. 5.2.2 Global Venous Leg Ulcers Treatment Sales by Region: 2027-2032
  5. 5.3 Global Venous Leg Ulcers Treatment Revenue by Region: 2021-2032
  6. 5.3.1 Global Venous Leg Ulcers Treatment Revenue by Region: 2021-2026
  7. 5.3.2 Global Venous Leg Ulcers Treatment Revenue by Region: 2027-2032
  8. 5.4 North America Venous Leg Ulcers Treatment Market Facts & Figures by Country
  9. 5.4.1 North America Venous Leg Ulcers Treatment Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Venous Leg Ulcers Treatment Sales by Country (2021-2032)
  11. 5.4.3 North America Venous Leg Ulcers Treatment Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Venous Leg Ulcers Treatment Market Facts & Figures by Country
  16. 5.5.1 Europe Venous Leg Ulcers Treatment Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Venous Leg Ulcers Treatment Sales by Country (2021-2032)
  18. 5.5.3 Europe Venous Leg Ulcers Treatment Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Venous Leg Ulcers Treatment Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Venous Leg Ulcers Treatment Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Venous Leg Ulcers Treatment Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Venous Leg Ulcers Treatment Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Venous Leg Ulcers Treatment Market Facts & Figures by Country
  41. 5.7.1 South America Venous Leg Ulcers Treatment Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Venous Leg Ulcers Treatment Sales by Country (2021-2032)
  43. 5.7.3 South America Venous Leg Ulcers Treatment Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Venous Leg Ulcers Treatment Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Venous Leg Ulcers Treatment Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Venous Leg Ulcers Treatment Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Venous Leg Ulcers Treatment Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Venous Leg Ulcers Treatment Sales by Type (2021-2032)
  2. 6.1.1 Global Venous Leg Ulcers Treatment Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Venous Leg Ulcers Treatment Sales Market Share by Type (2021-2032)
  4. 6.2 Global Venous Leg Ulcers Treatment Revenue by Type (2021-2032)
  5. 6.2.1 Global Venous Leg Ulcers Treatment Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Venous Leg Ulcers Treatment Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Venous Leg Ulcers Treatment Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Venous Leg Ulcers Treatment Sales by Application (2021-2032)
  2. 7.1.1 Global Venous Leg Ulcers Treatment Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Venous Leg Ulcers Treatment Sales Market Share by Application (2021-2032)
  4. 7.2 Global Venous Leg Ulcers Treatment Revenue by Application (2021-2032)
  5. 7.2.1 Global Venous Leg Ulcers Treatment Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Venous Leg Ulcers Treatment Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Venous Leg Ulcers Treatment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Venous Leg Ulcers Treatment Value Chain Analysis
  2. 8.1.1 Venous Leg Ulcers Treatment Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Venous Leg Ulcers Treatment Production Mode & Process
  5. 8.2 Venous Leg Ulcers Treatment Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Venous Leg Ulcers Treatment Distributors
  8. 8.2.3 Venous Leg Ulcers Treatment Customers
9 Global Venous Leg Ulcers Treatment Analyzing Market Dynamics
  1. 9.1 Venous Leg Ulcers Treatment Industry Trends
  2. 9.2 Venous Leg Ulcers Treatment Industry Drivers
  3. 9.3 Venous Leg Ulcers Treatment Industry Opportunities and Challenges
  4. 9.4 Venous Leg Ulcers Treatment Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst